In recent years, "technological skin care" can be said to be a hot topic in the cosmetics industry. At a time when the number of "ingredient parties" is increasing day by day, "black technology" skin care products are often very popular. In this context, the cosmetics industry is

In recent years, "technological skin care" can be said to be a hot topic in the cosmetics industry. At a time when the number of "ingredient parties" is increasing day by day, "black technology" skin care products are often very popular. In this context, the cosmetics industry is no longer a competition between brands and publicity, but more a competition of innovative scientific research capabilities. In the domestic anti-aging market, Marubi has always been an unavoidable "peak". Under the long-term leadership of Sun Huaiqing, chairman and CEO of Marubi, Marubi has always followed the path of scientific research to promote development, and has solidified its reputation as the number one brand in the anti-aging category in China with its solid scientific and technological strength.

Sun Huaiqing once said that only technological innovation can change the world. To create a world-class beauty brand, it does not rely on the ability to tell stories and follow suit, but on innovation and breakthroughs in core technologies and core raw materials. As he said, technology is the primary productive force. The current bottlenecks in research on the recombinant collagen track are mostly at the technical level. How to improve the application technology of recombinant collagen is the key to the development of this track. The fundamental basis of the anti-aging activity of

collagen is that it has a unique spatial structure - a triple helix structure. The preparation of recombinant collagen with a triple helix structure has also become the focus of technological breakthroughs in this field. Professor Xiong Sheng, chief scientist of Marubi's recombinant collagen, once said that Marubi's R&D team has used the international cutting-edge AI technology AlphaFold to predict that Marubi's recombinant double collagen has a triple helix structure and a C-Pro buckle, and has achieved 100% sequence consistency with the human amino acid .

(The green part in the picture represents the predicted stable triple-helical structure region, and the stronger the green, the higher the credibility of the prediction result)

In the Alphafold structure of the recombinant collagen synthesized by Marumi, the green parts (stable triple-helical structures with high confidence) are more and more obvious. This shows that compared with other recombinant collagens, the recombinant collagen synthesized by Marumi has a more orderly and regular structure, and a higher degree of helix. In addition, after rigorous evaluation, Marubi's recombinant double collagen has significant effects in promoting cell adhesion and cell migration, as well as significant cell proliferation activity. It can also promote the expression of type I and type III collagen in cells, and the improvement rate is significantly better than other collagens.

At present, the recombinant collagen developed by other companies on the market does not have a highly stable triple helix structure, which leads to the lack of strong support for skin absorption. It "appears to be useful but is actually useless" and treats the symptoms but not the root cause. Marubi's outstanding research results demonstrate Marubi's continuous pursuit of recombinant collagen technology, and also confirm the correctness of Sun Huaiqing's long-termism and scientific research to promote the company's progress.

With the rise of new consumer groups and frequent pain points in the skin care field, the emergence of Marubi's recombinant double collagen meets consumers' high-end anti-aging skin care needs to a certain extent. Under the leadership of Sun Huaiqing, Marumi will continue to invest more than 100 million in research on recombinant collagen for 10 years, using technological innovation as the starting point to achieve the brand's long-term leadership in the recombinant collagen track.